IN THE NEWS IN THE NEWS SNN Network Salarius CEO, David Arthur discusses the future of the company with SNN Network The Fly Salarius, Aspire Capital announce a $10.9M stock purchase agreement Houston Business Journal Houston pharma co. lands nearly $11M investment from Chicago group WuXi AppTec Salarius Believes Children Should Not Be Left Behind in the Fight Against Cancer Biotuesdays David Arthur discusses Seclidemstat with Bio Tuedays NASDAQ Salarius’ CEO David Arthur Nasdaq Introduction Globe Newswire Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell TD Ameritrade Salarius’ CEO David Arthur on the Fight Against Cancer NASDAQ SALARIUS PHARMACEUTICALS, INC. RINGS THE NASDAQ STOCK MARKET OPENING BELL Health Professional Radio Phase 1 Trial for the Treatment of Ewing Sarcoma – Salarius Pharmaceuticals TheFly.com TheFly Speaks with Salarius CEO David Arthur Pharmaceutical Executive Biopharmaceutical Enterprises Pursuing Unconventional Paths to Public Markets Pharmaceutical Executive Houston oncology co. aims to grow after merger announcement Houston Chronical Houston-based Salarius to merge with Flex Pharma Houston Business Journal Houston oncology co. to merge with Boston’s struggling Flex Pharma Houston Business Journal Pharma company to relocate to Houston following CPRIT grant Investor Tools
IN THE NEWS SNN Network Salarius CEO, David Arthur discusses the future of the company with SNN Network The Fly Salarius, Aspire Capital announce a $10.9M stock purchase agreement Houston Business Journal Houston pharma co. lands nearly $11M investment from Chicago group WuXi AppTec Salarius Believes Children Should Not Be Left Behind in the Fight Against Cancer Biotuesdays David Arthur discusses Seclidemstat with Bio Tuedays NASDAQ Salarius’ CEO David Arthur Nasdaq Introduction Globe Newswire Salarius Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell TD Ameritrade Salarius’ CEO David Arthur on the Fight Against Cancer NASDAQ SALARIUS PHARMACEUTICALS, INC. RINGS THE NASDAQ STOCK MARKET OPENING BELL Health Professional Radio Phase 1 Trial for the Treatment of Ewing Sarcoma – Salarius Pharmaceuticals TheFly.com TheFly Speaks with Salarius CEO David Arthur Pharmaceutical Executive Biopharmaceutical Enterprises Pursuing Unconventional Paths to Public Markets Pharmaceutical Executive Houston oncology co. aims to grow after merger announcement Houston Chronical Houston-based Salarius to merge with Flex Pharma Houston Business Journal Houston oncology co. to merge with Boston’s struggling Flex Pharma Houston Business Journal Pharma company to relocate to Houston following CPRIT grant
